Monoclonal Antibody Therapy in Treating Children With Metastatic Neuroblastoma in Second Remission

Completed · Phase 2

Conditions studied: Neuroblastoma

In brief

RATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. PURPOSE: Phase II trial to study the effectiveness of monoclonal antibody in treating children with metastatic neuroblastoma in second remission.

Key facts

Study ID

NCT00002458

Run by

Memorial Sloan Kettering Cancer Center

Starts

1987-11-01

Expected to finish

2001-09-01

Last updated by the study team

2013-06-05

Who can join

Age: any, up to 18. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Memorial Sloan-Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.